Lexaria Bioscience(LEXX)
$4.18-0.46 (-9.91%)
LEXX
Lexaria Bioscience stock drug pipeline
$4.18
At close:-0.46 (-9.91%)
Lexaria Bioscience (LEXX) Drug Pipeline
250 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Arm 1 - Dehydratech-Cbd Alone, Arm 2 - Dehydratech-Semaglutide Alone, Arm 3 - Dehydratech-Cbd In Combination With Dehydratech-Semaglutide, Arm 4 - Rybelsus Medication (Semaglutide) Alone, Arm 5- Tirzepatide | Type2diabetes | Phase I | Active Not Recruiting | Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants | Oct 16, 2024 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Arm 1 - Dehydratech-Cbd Alone, Arm 2 - Dehydratech-Semaglutide Alone, Arm 3 - Dehydratech-Cbd In Combination With Dehydratech-Semaglutide, Arm 4 - Rybelsus Medication (Semaglutide) Alone, Arm 5- Tirzepatide | Phase I | Type2diabetes | Active Not Recruiting | Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants | Oct 16, 2024 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Lexaria Bioscience Corp. (LEXX) have in its pipeline
Lexaria Bioscience LEXX is currently developing the following drugs: Arm 1 - Dehydratech-Cbd Alone, Arm 2 - Dehydratech-Semaglutide Alone, Arm 3 - Dehydratech-Cbd In Combination With Dehydratech-Semaglutide, Arm 4 - Rybelsus Medication (Semaglutide) Alone, Arm 5- Tirzepatide. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
